Laser trabeculoplasty as primary therapy for glaucoma
Record ID 31998008880
The author aims to determine whether the use of laser trabeculoplasty would be better than the current use of topical medication as primary therapy for glaucoma.
Authors' results and conclusions: Studies suggested that less than half the laser-first eyes were successfully controlled without medications by two years, so the benefits of laser over medication will be only transient. But beginning with laser treatment means that patients will be spared the need for antiglaucoma medications and their potential side effects, and patient compliance is eliminated as a factor in control of glaucoma (studies have shown that 18%-35% of prescribed doses are not administered).
Authors' recomendations: With the available evidence, the author considers that quantification of benefits is not possible and long term studies of effectiveness in delaying blindness are needed. The author concludes that it may be a useful adjunct therapy for patients who are unable to administer or tolerate medical therapy.
Authors' methods: Systematic review
Project Status: Completed
URL for project: http://www.wihrd.soton.ac.uk
Year Published: 1996
English language abstract: An English language summary is available
Publication Type: Not Assigned
- Costs and Cost Analysis
- Laser Therapy
Organisation Name: Wessex Institute for Health Research and Development
Contact Address: Pauline King. Wessex Institute for Health Research and Development, Boldrewood Medical School, Bassett Crescent East, Highfield, Southampton. SO16 7PX Tel. +44 1703 595661 Fax +44 1703 595662
Copyright: Wessex Institute for Health Research and Development (WIHRD)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.